Characteristics
All participants (n=333)
Deceased (n=83)
Alive (n=250)
Age, median, years 59 (19-91) 67 (26-91) 57% (19-86)
<50
23.4% (78)
10.8% (9)
27.6% (69)
50-59
28.5% (95)
19.3% (16)
31.6% (79)
60-69
27.3% (91)
33.7% (28)
25.2% (63)
70-79
15.3% (51)
22.9% (19)
12.8% (32)
>80
5.4% (18)
13.3% (11)
2.8% (7)
Sex, %(n) Sex, %(n) Sex, %(n) Sex, %(n)
Male
58.6% (195)
66.3% (55)
56% (140)
Female
41.4% (138)
33.7% (28)
44% (110)
Weighted Charlson comorbidity index, %(n) Weighted Charlson comorbidity index, %(n) Weighted Charlson comorbidity index, %(n) Weighted Charlson comorbidity index, %(n)
0
11.7% (39)
2.4% (2)
14.8% (37)
1
30.9% (103)
18.1% (15)
35.2% (88)
2
20.1% (67)
15.7% (13)
21.6% (54)
>3
37.2% (124)
63.9% (53)
28.4% (71)
Comorbidities within the Charlson comorbidity index, %(n) Comorbidities within the Charlson comorbidity index, %(n) Comorbidities within the Charlson comorbidity index, %(n) Comorbidities within the Charlson comorbidity index, %(n)
Myocardial infarction
11.4% (38)
24.1% (20)
7.2% (18)
Congestive heart failure
15.3% (51)
24.1% (20)
12.4% (31)
Cerebrovascular disase
25.2% (84)
31.3% (26)
23.2% (58)
Chronic pulmonary disease
3.6% (12)
4.8% (4)
3.2% (8)
Ulcer disease
0.6% (2)
0% (0)
0.8% (2)
Mild liver disease
0.3% (1)
1.2% (1)
0% (0)
Diabetes mellitus
33.6% (112)
49.4% (41)
28.4% (71)
Hemiplegia
1.2% (4)
0% (0)
1.6% (4)
Renal disease
11.4% (38)
27.7% (23)
6% (15)
Diabetes wih end organ damage
0.6% (2)
0% (0)
0.8% (2)
Any malignancy
0.9% (3)
0% (0)
1.2% (3)
AIDS
0.9% (3)
2.4% (2)
0.4% (1)
Length of stay, median, day 8 (1-37) 7 (1-26) 8% (1-37)